. Establishment of tamoxifen-resistant cells. (A) Tamoxifen sensitivity of MCF-7/TR1, MCF-7/TR2 and MCF-7/TR3. Cells were treated with different concentrations of tamoxifen (1, 2, 5, 10, 20 μM) for 72 h, and cell proliferation was determined by MTT assay. (B) Colony-forming ability of MCF-7 and MCF-7/TR1, TR2, TR3 cells in the presence of tamoxifen. Cells were incubated with 5 μM tamoxifen for 7-10 days, the colony numbers of each group were counted by Image J analysis software. The experiments were repeated at least 3 times, * p < 0.05, ** p < 0.01 by one-way ANOVA.
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